A Multicentre, Open label, Randomized, Comparative, Parallel Group, Active-controlled, Phase III Clinical Trial to Evaluate Safety and Efficacy of Arbekacin Sulphate Injection versus Vancomycin Injection in Patients Diagnosed with MRSA Infection.
Conclusion: Arbekacin can be considered as safe and effective alternative to vancomycin in the management of MRSA infections.
PMID: 31313549 [PubMed - in process]
Source: Journal of the Association of Physicians of India - Category: General Medicine Tags: J Assoc Physicians India Source Type: research
More News: Clinical Trials | General Medicine | India Health | Infectious Diseases | Japan Health | Microbiology | MRSA | Study | Superbugs